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The TAFII250 Subunit of TFIID
Has Histone Acetyltransferase Activity
Craig A. Mizzen,1,7 Xiang-Jiao Yang,2,7 shown that functional preinitiation complexes can be
assembled in a step-wise fashion. The first step is TFIIDTetsuro Kokubo,3 James E. Brownell,1
binding, a process that may be facilitated by TFIIA. TheAndrew J. Bannister,4 Tom Owen-Hughes,5
subsequent binding of TFIIB creates a platform that isJerry Workman,5 Lian Wang,6
in turn recognized by a complex containing RNA poly-Shelley L. Berger,6 Tony Kouzarides,4
merase II and TFIIF. Further incorporation of TFIIE andYoshihiro Nakatani,2 and C. David Allis1
TFIIH completes preinitiation complex formation. Re-1Department of Biology
cent studies have revealed that complexes of RNA poly-University of Rochester
merase II, general initiation factors, and cofactors mayRochester, New York 14627
enter the preinitiation complex as a preassembled unit2Laboratory of Molecular Growth Regulation
(reviewed by Koleske and Young, 1995; Orphanides etNational Institute of Child Health
al., 1996; Pugh, 1996). Although the assembly pathwayand Human Development
most relevant to the in vivo situation remains unclear,National Institutes of Health
TFIID binding to the promoter could be an importantBethesda, Maryland 20892
step for promoter activation in different pathways since3Nara Institute of Science and Technology
TFIID is the only component of the preinitiation complexNara, 630-01
that is capable of binding specifically to core promoters.Japan
Control of promoter recognition by TFIID appears to4Wellcome/CRC Institute
represent an important pathway for transcriptional regu-Cambridge University
lation. TFIID is a target for a number of transcriptionalCambridge CB2 1QR
activators whose interactions with TFIID may enhanceUnited Kingdom
the rate of promoter binding by TFIID or stabilize TFIID–5Department of Biochemistry
promoter complexes (reviewed by Kingston and Green,and Molecular Biology
1994; Struhl, 1996). TFIID itself is a multimeric proteinPennsylvania State University
complex consisting of TBP and TBP-associated factorsUniversity Park, Pennsylvania 16802
(TAFIIs) whose sizes range from Mr z10,000 to >200,0006Wistar Institute
(for review, see Burley and Roeder, 1996). To date,Philadelphia, Pennsylvania 19104
cDNAs encoding nine TAFII subunits of Drosophila TFIID
(dTAFII230, 150, 110, 85, 62, 42, 28a, 28b, and 22) have
been cloned.Although TBP alone can bind core promot-Summary
ers containing TATA elements and support basal tran-
scription in conjunction with other general transcriptionThe transcription initiation factor TFIID is a multimeric
factors and RNA polymerase II, TAFIIs are required forprotein complex composed of TATA box–binding pro-
activated transcription. Several TAFIIs have been showntein (TBP) and many TBP-associated factors (TAFIIs).
to provide interaction sites for distinct activators andTAFIIs are important cofactors that mediate activated
transcription-initiation factors. These interactions couldtranscription by providing interaction sites for distinct
serve either to facilitate TFIID recruitment per se or toactivators. Here, we present evidence that human
induce conformational alterations that affect recruit-TAFII250 and its homologs in Drosophila and yeast ment or function of downstream factors (reviewed inhave histone acetyltransferase (HAT) activity in vitro.
Orphanides et al., 1996; Roeder, 1996; Verrijzer andHAT activity maps to the central, most conserved por-
Tjian, 1996).tion of dTAFII230 and yTAFII130. The HAT activity of Recent studies showing capabilities for transcrip-dTAFII230 resembles that of yeast and human GCN5 tional activation in yeast depleted of the TAF subunitsin that it is specific for histones H3 and H4 in vitro.
of TFIID (Moqtaderi et al., 1996; Walker et al., 1996)Our findings suggest that targeted histone acetylation
suggest redundant pathways for activator responses.
at specific promoters by TAFII250 may be involved in Consistent with this, direct linkage of enhancer-bindingmechanisms by whichTFIID gains access to transcrip-
domains and either TBP (Chatterjee and Struhl, 1995;tionally repressed chromatin.
Klages and Strubin, 1995), TAFs (reviewed in Moqtaderi
et al., 1996), or subunits within the RNA polymerase
Introduction II holoenzyme (Barberis et al., 1995) can bypass the
requirement for activation domains. These lines of evi-
Transcription of protein-coding genes in eukaryotes re- dence suggest that recruitment of either factor may lead
quires the orchestrated assembly of a large preinitiation to at least some transcriptional activation, although mul-
complex containing a well-studied collection of general tiple interactions could be required for full activation.
transcription factors, TFIIA, TFIIB, TFIID, TFIIE, TFIIF, Central to eukaryotic transcriptional regulation are
and TFIIH and RNA polymerase II, at promoters (re- how TFIID gains access to a chromatin template and
viewed by Burley and Roeder, 1996; Orphanides et al., how a stable association is maintained within the chro-
1996; Roeder, 1996). Reconstitution of transcription has mosomal enviroment. A potentially relevant finding is
the presence of a histone octamer-like substructure in
7 These authors contributed equally to this work. TFIID (Hoffmann et al., 1996; Nakatani et al., 1996; Xie
Cell
1262
et al., 1996). The N-terminal regions of the dTAFII42 and
dTAFII62 proteins have sequence similarities with the
C-terminal core domains, but not the N-terminal tails,
of histones H3 and H4, respectively (Kokubo et al.,
1994a). The crystal structure of the N-terminal portions
of dTAFII42/dTAFII62 reveals that they adopt the canoni-
cal histone fold, consisting of two short a helices flank-
ing a long, central a helix (Xie et al., 1996). Moreover, the
dTAFII42/dTAFII62 complex exists as a heterotetramer,
resembling the (H3/H4)2 heterotetrameric core of the
histone octamer. In addition, biochemical studies with
human TAFIIs (hTAFIIs) suggest that TFIID contains a
histone octamer-like structure composed of two dimers
of the histone H2B-like TAFII (hTAFII15/20 or dTAFII28a)
attached to a tetramer of histones H3/H4-like TAFIIs
(Hoffmann et al., 1996). These similarities to histone
complexes have prompted the suggestion that TAFII
complexes may wrap and interact with promoter DNA
in a nucleosome-like structure (Hoffmann et al., 1996).
Biochemical studies have demonstrated that physical
interactions of activators with general transcription fac-
tors play an important role in activated transcription
from naked DNA templates (reviewed by Burley and
Roeder, 1996; Orphanides et al., 1996; Roeder, 1996).
Figure 1. HeLa Nuclear Extracts Contain a High-Molecular-Weight
Moreover, the recent discovery that dTAFII230/hTAFII250 Polypeptide with HAT Activity
possesses kinase activity that phosphorylates the
(A) Aliquots of HeLa cell crude nuclear extract were resolved on
RAP74 subunit of TFIIF in vitro (Dikstein et al., 1996) 8% SDS–PAGE gels containing histone or BSA as indicated and
suggests that enzymatic mechanisms are also involved, processed to detect acetyltransferase activity. The arrow denotes
although the role of phosphorylation has not been dem- an activity band in the activity gel containing histone with an appar-
ent molecular weight similar to that of hTAFII250, as shown by immu-onstrated. Additionally, various enzymatic activities,
noblotting in (B).such as histone acetyltransferases (HATs), histone ki-
(B) An aliquot of HeLa-cell crude nuclear extract was resolved on annases, and DNA helicases, may be required for tran-
8% SDS–PAGE gel and analyzed by Western blotting using antisera
scriptional regulation within the context of nucleosomal specific for hTAFII250. The arrow denotes hTAFII250. The activity
and higher-order chromatin structure that represses gels and the immunoblot were aligned using prestained molecular
transcription in general (reviewed by Owen-Hughes and weight markers, as indicated on the left with molecular weight given
Workman, 1994; Felsenfeld, 1996). in kilodaltons.
A large number of studies have established a correla-
tion between chromatin transcriptional activation, i.e.,
scription from natural chromatin templates by increas-
derepression, and acetylation of highly conserved lysine
ing the accessibility of TFIID to promoters. Our dataresidues situated in the amino-terminal tails of the core
provide additional support for the notion that targetedhistones (reviewed by Loidl, 1994; Turner and O’Neill,
histone acetylation represents an important pathway in1995; Brownell and Allis, 1996). Although the mechanis-
gene activation. We favor the view that eukaryotic cellstic details underlying acetylation-mediated activation
have evolved a scheme of targeted histone acetylationfrom chromatin templates remain unclear, it is generally
wherein HAT activities, and potentially other chromatin-thought that neutralization of the positive charge of ly-
modifying activities (for example, Roest et al., 1996; re-sine residues upon acetylation perturbs histone-DNA
viewed by Kaiser and Meisterernst, 1996), are recruitedcontacts within nucleosomal and higher-order structure
to specificpromoters through selective interactions withand influences histone interactions with specific nonhis-
activator proteins.tone regulatory proteins (reviewed by Wolffe, 1994;
Brownell and Allis, 1996). The recent findings that the
Resultsyeast transcriptional adaptor-protein GCN5 (Brownell et
al., 1996) and related human proteins (hGCN5, Wang et
A Large Molecular-Weight, TBP-Associatedal., 1997; hP/CAF, Yang et al.,1996) possess HAT activity
Polypeptide Has HAT Activityin vitro provide strong evidence that histone acetylation
We recently demonstrated the utility of an activity gelis linked to transcriptional activation and suggest that
assay to detect proteins with HAT activity in complexhistone acetylation may be a targeted phenomenon (re-
samples (Brownell and Allis, 1995; Brownell et al., 1996).viewed by Brownell and Allis, 1996; Wolffe and Pruss,
In this technique, samples are resolved in SDS–PAGE1996).
gels containing histones prior to detection of HAT activ-In this report, we demonstrate that, like the GCN5
ity, and thus the molecular weight estimates of activeprotein family, TAFII250 and its homologs in Drosophila
polypeptides can be determined. Using this assay toand yeast (hereafter referred to collectively as TAFII250)
characterize a crude HeLa nuclear extract, we identifiedhave HAT activity in vitro. This finding suggests that
a polypeptide with a molecular weight of approximatelyacetylation of histone amino termini at or near core pro-
moters by TAFII250 could be involved in facilitating tran- 200 kDa that possessed strong HAT activity (Figure 1A).
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Figure 2. Anti-TBP Antibodies Immunoprecipitate HAT Activity
(A and B) Immunoprecipitations were performed from COS whole-
Figure 3. Recombinant Drosophila TAFII230 Possesses HAT Activitycell extracts (A) and HeLa-cell nuclear extracts (B) with the indicated
(A) FLAG epitope–tagged, affinity-purified recombinant dTAFII230antibodies. After extensive washing, the resulting immune com-
and FLAG–dTAFII62 were resolved on 8% SDS gels containing his-plexes were assayed for their ability to acetylate either free histones
tone or BSA as indicated and processed to detect acetyltransferaseor BSA. The anti-CBP antibody served as a positive control since
activity.both CBP and the associated P/CAF have HAT activity (see text).
(B) Identical dTAFII230 and dTAFII62 samples were electrophoresedThe anti-E1A antibody served as a negative control since E1A is
in a parallel SDS–PAGE gel and immunoblotted with antisera to thenot detectable in these cell lines.
FLAG epitope.(C) The anti-TBP immunoprecipitate was resolved on an 8% SDS–
(C) Identical dTAFII230 and dTAFII62 samples were electrophoresedPAGE gel and analyzed by Western blotting using antisera specific
in a parallel SDS–PAGE gel and stainedwith Coomassie blue. Arrowsfor hTAFII250. The arrow denotes hTAFII250.
in (A), (B), and (C) indicate the position of full-length dTAFII230.
This activity appeared to be specific for histone and extracts was routinely more than 6-fold greater than
was not due to autoacetylation, since activity was not background (Figure 2A).
detected when a sample was analyzed on a gel con- HAT activityassociated with anti-TBP immunoprecipi-
taining BSA. Interestingly, we did not detect activities tates was approximately 5-fold greater than background
resembling hGCN5 (apparent molecular weight 60 kDa) when immunoprecipitates were prepared from whole-
or hP/CAF (apparent molecular weight 95 kDa) in crude cell extracts (Figure 2A) and from nuclear extracts (Fig-
HeLa nuclear extract, suggesting that the total activities ure 2B). Moreover, the HAT activity associated with TBP
of these known HATs in this sample are lower or that was specific to histones, since BSA was not acetylated
these proteins are not renatured as readily in the assay by anti-TBP immunoprecipitates under similar conditions
procedure. Due to the similarity in molecular weight, we (Figure 2B). As expected, Western blot analysis con-
speculated that the active species might be hTAFII250, firmed that hTAFII250 was present in the anti-TBP immu-
the 250 kDa (nominal) subunit of human TFIID (Hisatake noprecipitate (Figure 2C). Together, these results sug-
et al., 1993; Ruppert et al., 1993). Immunoblot analysis of gest that HAT activity may be attributable to hTAFII250
the nuclear extract using an hTAFII250-specific antisera and further suggest that this activity is preserved in
(Figure 1B) demonstrated that the immunoreactive band TFIID.
possessed electrophoretic mobility similar to that of the
detected HAT, further supporting the hypothesis that Recombinant dTAFII230 Has HAT Activity
hTAFII250 has HAT activity in this assay. To rigorously test the hypothesis that TAFII250 has HAT
To further test this hypothesis and to determine if HAT activity, we expressed dTAFII230 as a FLAG epitope–
activity could be detected in TAFs, we used antibodies tagged protein in Sf9 cells using baculovirus-mediated
to TBP to immunoprecipitate TBP–TAF complexes from transfection and assayed the affinity-purified recombi-
COS whole-cell extracts and HeLa-cell nuclear extracts nant protein for HAT activity. Recombinant dTAFII230
and assayed the immunoprecipitates for HAT activity. displayed acetyltransferase activity when assayed with
To monitor the specificity of this procedure, two controls a histone-containing gel but not when the gel contained
were employed. First, an E1A-specific antibody was BSA (Figure 3A). The absence of HAT activity in a nonho-
used as a negative control. Second, a CBP-specific anti- mologous recombinant protein, FLAG–dTAFII62, pre-
body was used as a positive control, since CBP per se pared by identical procedures indicated that HAT activ-
(Ogryzko et al., 1996) and its associated hP/CAF (Yang ity was a property of dTAFII230 rather than contaminants
et al., 1996) have HAT activity. from baculovirus-infected Sf9 cells. Similar amounts of
The results of these immunoprecipitation-HAT assays dTAFII62 and dTAFII230 were detected at their respective
are shown in Figure 2. A low level of HAT activity was molecular weights by both immunoblot analysis with
associated with anti-E1A immunoprecipitates prepared antisera to the FLAG epitope (Figure 3B) and Coomassie
from whole-cell extract (Figure 2A) and nuclear extract blue staining (Figure 3C). Furthermore, Coomassie blue
(Figure 2B). This represents background activity since staining revealed that the recombinant proteins were
we found several other antibodies against nuclear pro- highly purified; only low levels of a small set of ex-
teins precipitated similar amounts of activity (data not traneous proteins were detected. These data demon-
shown). In contrast, the amount of HAT activity associ- strate that HAT activity is associated with recombinant
dTAFII230 under the conditions employed.ated with anti-CBP immunoprecipitates from whole-cell
Cell
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Substrate Specificity of Recombinant
dTAFII230 HAT Activity
To characterize the recombinant dTAFII230 HAT activity
further, we performed HAT assays in solution with puri-
fied protein. Acetylation of a HeLa core histone mix-
ture and individual HeLa core histones, purified by
reverse-phase high pressure liquid chromatography
(HPLC), was measured by a filter-binding assay and by
fluorography (Figure 4). As a positive control, we as-
sayed a crude extract of recombinant hGCN5 expressed
in bacteria. Extracts of uninduced bacteria and purified
dTAFII62 were used as negative controls for hGCN5 and
dTAFII230, respectively. Liquid-scintillation counting of
reactants retained by P81 filters (Figure 4A) showed that
both hGCN5 and dTAFII230, in contrast to uninduced
bacterial extract or dTAFII62, catalyzed efficient [3H]-
acetate transfer to the HeLa core histone mixture. In
agreement with the activity gel assay (Figure 3), acetate
incorporation into BSA was not observed with either
hGCN5 or dTAFII230, nor was acetylation of proteins
endogenous to the enzyme preparations detected.
Given that the amino-terminal portions of dTAFII42 and
dTAFII62 adopt structures similar to the histone fold and
can form a (dTAFII42/dTAFII62)2 heterotetramer resem-
bling the (H3/H4)2 tetramer of nucleosomes (Xie et al.,
1996), we tested these TAFs as substrates for acetyla-
tion. Consistent with the lack of sequences related to
the histone amino-terminal tails in dTAFII42/dTAFII62,
they were not acetylated by dTAFII230 or hGCN5 (data
not shown).
Histone substrates acetylated by dTAFII230 and hGCN5
in vitro were identified by fluorography. As shown in the
upper portion of Figure 4B, H3 and H4 were the major
acetate acceptors when the HeLa core histone mixture
(lane 1) was incubated with dTAFII230. H3 and H4 were
acetylated by dTAFII230 regardless of whether they were
presented individually (lanes 4 and 5) or as part of the
mixture. Although H2A was acetylated by dTAFII230
when presented individually (lane 2), little or no H2A
acetylation was detected in the core histone mixture.
H2B was not acetylated by dTAFII230 when presented Figure 4. Substrate Specificities of Drosophila TAFII230 and Human
GCN5individually (lane 3) or as part of the mixture. No acetyla-
tion was detected in a control reaction where H4 (or H3, (A) Acetylation of proteins endogenous to enzyme preparations (no
substrate) BSA and HeLa core histones by recombinant dTAFII230data not shown) and [3H]-acetyl-CoA were incubated
and hGCN5 in vitro was assessed by measuring 3H-acetate incorpo-without enzyme (lane 6). When an equimolar mixture
ration using a filter-binding assay. Uninduced bacterial extract (unin-of H2A, H2B, H3, and H4, reconstituted from purified
duced) and recombinant dTAFII62 were used as negative controlsfractions (lane 7), was employed as substrate, acetyla- for hGCN5 and dTAFII230, respectively.
tion of H3 and H4 was indistinguishable from that seen (B) Specificity of HeLa core histone acetylation by dTAFII230 (two
in the histone mixture prior to purification. upper panels) and hGCN5 (two lower panels) was determined by
The dual H3 and H4 specificity of dTAFII230 differed fluorography of acetylated reaction products resolved on SDS–
PAGE gels. Fluorograms are shown aligned with the correspondingfrom a strong preference for only H3 displayed by
Coomassie blue–stained gels as indicated. Lane 1 shows unfraction-hGCN5. As shown in the lower panels of Figure 4B,
ated HeLa core histone mixture; lanes 2–5, reverse-phase HPLC-H3 was the preferred substrate for hGCN5 under all
purified HeLa histones H2A, H2B, H3, and H4, respectively; lane 6,
conditions tested (see also Wang et al., 1997). Acetyla- reverse-phase HPLC-purified HeLa H4 incubated with [3H]-acetyl-
tion of H2A, H2B, and H4 by hGCN5 was not detected CoA but without added enzyme; and lane 7, equimolar mixture of
in the histone mixture (lane 1) or when presented individ- HeLa core histones reconstituted from RP-HPLC–purified fractions.
ually (lanes 2, 3, and 5, respectively). Based on approxi- The positions of the individual histones in the gels are indicated at
the left of the figure. The lack of H4 acetylation by hGCN5 comparedmate measurements, we estimate that the specific activ-
to that described by Yang et al. (1996) may be related to differencesity of hGCN5 (dpm 3H-acetate transferred/pmol enzyme)
in the recombinant proteins employed.is two to four times that of dTAFII230 (data not shown).
Site Specificity of Recombinant dTAFII230
closely correlated with distinct biological processes (seeHAT Activity
Sobel et al., 1995; Turner and O’Neill, 1995). To deter-Utilization of specific acetylation sites within the core
histone amino termini is remarkably nonrandom and mine whether specific residues modified by dTAFII230
Histone Acetylation by TAFII250
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site for both hGCN5 and dTAFII230. Interestingly, this
same residue has recently been shown to be the pre-
ferred site of H3 acetylation by yeast GCN5 (yGCN5) in
vitro (Kuo et al., 1996). While little acetylation of the
unacetylated H4 peptide was seen with hGCN5, this
peptide was a good substrate for dTAFII230, in agree-
ment with the results obtained with intact histones (Fig-
ure 4B).
Putative Catalytic Domain of dTAFII230
and yTAFII130
To determine the portion of the dTAFII230 molecule
responsible for HAT activity, we expressed a series
of C-terminal deletion mutants as depicted in Figure
6A. A HAT-activity gel analysis employing equimolar
amounts of these proteins (Figure 6B) revealed that the
three mutants bearing the largest deletions, N545, N596,
and N885, did not possess detectable HAT activity. In
contrast, mutant proteins N1140 and N1480 and also
full-length dTAFII230 displayed HAT activity. These re-
sults suggest that sequences involved in histone ace-
tylation by dTAFII230 are situated between residues 1
and 1140. Furthermore, sequences between residues
885 and 1140 are critical for HAT activity, owing to possi-
ble roles in either catalysis or protein folding.
To further define the HAT catalytic domain, we ana-
lyzed the yeast homolog. yTAFII130 has 52% sequence
similarity with the N-terminal region of dTAFII230 (aa
1–1370) and lacks the region corresponding to the
C-terminus, including the bromodomains (see Figure
6A). The full-length recombinant yTAFII130 displays HATFigure 5. Site Specificity of Drosophila TAFII230 and Human GCN5
activity both in the activity gel and liquid assays (data(A and B) Acetylation of histone amino-terminal peptides by hGCN5
not shown).For mapping theHAT domain,yTAFII130 was(A) and dTAFII230 (B) was assessed by measuring 3H-acetate incor-
poration using the filter-binding assay. For each peptide substrate, divided into the three overlapping fragments, namely N
incubations without (open bars) and with (closed bars) enzyme were (aa 1–450), M (aa 354–817), and C (aa 690–1066) (Figure
performed in parallel. Acetylation of proteins endogenous to the 7A), each of which was expressed in and purified from
enzyme preparations was assessed by incubations without peptides
E. coli. HAT-activity gel analysis revealed that only theand is shown in the columns marked (E).
M region, representing the central portion of yTAFII130,(C) The structures of the peptidesused in (A) and (B) are shown. Sites
had HAT activity (Figure 7B). Significantly, this region iswhere e-N-acetyllysine was incorporated during peptide synthesis in
order to mimic sites that are acetylated in vivo are indicated by highly conserved in dTAFII230 and hTAFII250, aligning
(Ac). All peptides were MAP reagents except the diacetyl-(9/14)-H3 to residues 499–1003 of dTAFII230, which are included
peptide (denoted by the asterisk), which was synthesized with a in the active mutant protein N1140 (see Figure 6B).
C-terminal cysteine.
Among various acetyltransferases including theGCN5
protein family, cytoplasmic HAT1, and a-N-acetyltrans-
are the same as those modified by GCN5 (Kuo et al., ferases, putative acetyl-CoA binding sites (Lu et al.,
1996), we assessed the ability of dTAFII230 and hGCN5 1996) are conserved (Kleff et al., 1995; Borrow et al.,
to acetylate histone amino-terminal peptides synthe- 1996; Parthun et al., 1996; Reifsnyder et al., 1996). How-
sized with and without acetyl groups on the e-amino ever, multiple-alignment analysis (Lawrence et al., 1993)
groups of specific lysines. The peptide sequences and showed no significant sequence similarity within resi-
positions of acetate groups incorporated during synthe- dues 1 to 1140 of dTAFII230 (Figure 6) and 354 to 817
sis are depicted in Figure 5C. of yTAFII130 (Figure 7) to the putative acetyl-CoA binding
Acetylation of these peptides by hGCN5 and dTAFII- sites. Moreover, comparison of these regions with pro-
230 are shown in Figures 5A and 5B, respectively. Two tein-sequence databases (Altschul et al., 1990) showed
columns, representing assays performed without and no obvious sequence similarity to any other proteins.
with enzyme addition, are presented for each peptide These results lead us to suggest that the HAT catalytic
assayed. In agreement with the results described above domain of TAFII250 may represent a second type of HATfor intact histone, significant levels of acetylation by domain.
hGCN5 and dTAFII230 were observed for the unace-
tylated H3 peptide. Note that although the diacetyl-(9/
Discussion18)-H3 peptide was also a good substrate for both
hGCN5 and dTAFII230, neither enzyme acetylated the
HAT Activity Is Intrinsic to TAFII250diacetyl-(9/14)-H3 peptide significantly. Comparison of
In this report, we demonstrate that recombinantthe acetylation of the diacetyl-(9/14)-H3 and diacetyl-
(9/18)-H3 peptides suggests that Lys14 is a preferred dTAFII230 and yTAFII130 and natural hTAFII250 possess
Cell
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Figure 6. HAT Activity Maps to the N-termi-
nal Portion of dTAFII230
(A) The uppermost diagram depicts structural
and functional domains found in dTAFII230.
The TBP-binding domain (Kokubo et al.,
1994b; Nishikawa et al., 1997), the two protein
kinase domains (Dikstein et al., 1996), the
RAP74 binding domain (Ruppert and Tjian,
1995), and the two bromodomains (Kokubo
et al., 1993; Weinzierl et al., 1993) are indi-
cated. (G) denotes the glycine residue at posi-
tion 743 equivalent to the site of the ts-13
mutation in hamster TAFII250 that causes G1
arrest in cell-cycle progression (Hayashida et
al., 1994). C-terminal deletion mutants that
were tested for HAT activity in the activity gel
assay are depicted in the lower portion. Open
bars denote proteins that did not possess
HAT activity, and closed barsdenote proteins
with HAT activity.
(B) Equimolar amounts of the C-terminal–
deletion mutants depicted in (A) and full-
length dTAFII230 were compared using the
activity gel assay.
(C) Equivalent amounts of the C-terminal–
deletion mutants depicted in (A) and tested
for HAT activity in (B) are shown following
SDS–PAGE and Coomassie blue staining.
HAT activity and show that the HAT activity of dTAFII230 The Bromodomains of dTAFII230 Are
is specific for H3 and H4 in vitro. Several independent Dispensable for HAT Activity
lines of evidence suggest that these observations are Since the HAT activities of GCN5 and dTAFII230 both
not artifactual. Recombinant dTAFII230 displayed HAT show a strong preference for H3 as a substrate in vitro
activity in both the liquid and activity gel assays. The and since the only significant homology between these
activity gel assay, which involves denaturation of sam- proteins is found in their bromodomains (one in hGCN5
ples in 1% SDS (with boiling) prior to fractionation and and two in dTAFII230; see Figure 6A), we tested whether
subsequent renaturation within the gel matrix, strongly the bromodomain may play a role in histone recognition
suggests that the HAT activity detected is intrinsic to or binding. Deletion of the C-terminal 588 amino acids
dTAFII230. Polypeptides potentially associated with of dTAFII230 removes both of the bromodomains but
dTAFII230 following affinity purification are expected to does not affect HAT activity in vitro (N1480 in Figure 6)
dissociate and separate from the dTAFII230 polypeptide and does not alter the H3/H4 specificity of dTAFII230
during electrophoresis, and their reassociation during (data not shown). Thus, it is unlikely that the bromodo-
renaturation is prevented by entrapment within the gel main is involved in histone recognition or acetate trans-
matrix. fer by dTAFII230. This is supported by our finding that
However, one might argue the possibility that HAT yTAFII130, which lacks bromodomains, has HAT activ-
activity is catalyzed by polypeptides tightly associated ity in vitro (Figure 7). Moreover, the bromodomain in
with dTAFII230 in complexes that resist dissociation in yGCN5 is dispensable for HAT activity in vitro (Candau
1% SDS. The following results indicate that this is not et al., 1997).
the case. The use of stronger denaturing conditions (4% A function has not yet been demonstrated for the
SDS or 4% SDS plus 8 M urea) or dTAFII230 purified bromodomain in any protein, but it has been suggested
further by size-exclusion chromatography in buffer con-
to mediate protein–protein interactions (Haynes et al.,
taining 6 M guanidine hydrochloride gave results similar
1992; Tamkun et al., 1992). Given that the bromodomain
to those shown in Figure 3 (data not shown). Moreover,
is required for yGCN5 function in yeast (Marcus et al.,the active deletion mutants of dTAFII230 (N1140 and 1994), a role in targeting the HAT activity of GCN5 toN1480 in Figure 6) and of yTAFII130 ([M] in Figure 7)
appropriate chromatin loci hasbeen proposed (Brownellshow the expected molecular weights on both Coomas-
and Allis, 1996). However, our finding that both yTAFII130sie blue–stained gels and HAT-activity gels. Since the
and the dTAFII230 mutants lacking the bromodomainmutants of dTAFII230 and yTAFII130 were expressed in
possess HAT activity in vitro argues against a role ininsect cells and bacteria, respectively, and since the
substrate recognition.yTAFII130 mutants were purified using buffer containing
6 M guanidine hydrochloride, it is unlikely that the HAT
Substrate Specificity of the dTAFII230 HATactivity of both sets of mutantproteins is due to contami-
The dual H3/H4 substrate specificity of dTAFII230 is simi-nating polypeptides. Finally, our analyses of HeLa nu-
lar to that described previously for hGCN5 and P/CAFclear extract (Figure 1) and anti-TBP immunopre-
(Yanget al., 1996) and yGCN5 (Kuoet al., 1996). Similarly,cipitates (Figure 2) provide independent support that
hTAFII250 also has HAT activity. we have found that dTAFII230, like hGCN5 (Yang et al.,
Histone Acetylation by TAFII250
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that efficient acetylation of chromatin substrates by
HATs like GCN5 may require multimeric HAT complexes
containing subunits capable of transiently exchanging
with nucleosomal histones (Roth and Allis, 1996). It is
an intriguing possibility that the histone-like features of
TAFIIs described above may play a role in facilitating
chromatin acetylation by TAFII250.
Possible Significance of TAFII250 HAT Activity
Several lines of evidence suggest that acetylation or
removal of core histone amino termini enhances tran-
scription-factor binding to nucleosomal DNA (Lee et al.,
1993; Vettesse-Dadey et al., 1994). Nucleosome assem-
bly in vitro represses transcription of plasmids in vitro
unless TBP-promoter or TFIID–promoter complexes are
formed prior to nucleosome assembly (Workman and
Roeder, 1987; Meisterernst et al., 1990), suggesting that
nucleosomes inhibit binding of TBP or TFIID to natu-
ral (chromatin) templates. Moreover, experimental evi-
dence suggests that the amino termini of the core his-
tones mediate this inhibition. Imbalzano et al. (1994)
reported that TBP binding to a TATA box in nucleosomal
Figure 7. HAT Activity Maps to the Central Portion of yTAFII130 DNA is inhibited unless human SWI/SNF and ATP are
(A) The uppermost diagram depicts the structural and functional present. Significantly, SWI/SNF and ATP are not re-
domains found in yTAFII130. The TBP binding domain (T. Kokubo, quired for TBP binding when nucleosomes contain hy-
J. Nishikawa, and Y. N., unpublished data) is indicated. (G) denotes peracetylated histones. Similarly, Godde et al. (1995)
the glycine residue at position 561 equivalent to the site of the ts-
demonstrated that TBP binding occurs only when the13 mutation in hamster TAFII250 that causes G1-arrest in cell-cycle
TATA box is positioned within linker DNA at the edgeprogression (Hayashida et al., 1994). The three deletion mutants
of nucleosomes in which the core histone amino terminithat were tested for HAT activity in the activity gel assay are depicted
in the lower portion. Open bars denote proteins without HAT activity, are removed by proteolysis (presumably mimicking ace-
and closed bars denote proteins with HAT activity. tylation). These authors found that TBP does not bind
(B) Equimolar amounts of the deletion mutants depicted in (A) were nucleosomes containing intact core histones under any
compared using the activity gel assay. Repeated analyses confirmed
of the conditions tested. Taken together, these studiesthat the minor density visible in lane (C) is not an activity band but
demonstrate that core histone amino termini regulateis an artifact related to the crease apparent in the dried gel. The
the accessibility of the TATA box for binding by TBP.arrowhead indicates the position of the mutant protein M.
(C) Equivalent amounts of the deletion mutants depicted in (A) and Our data suggest that acetylation of nucleosomes at
tested for HAT activity in (B) are shown following SDS–PAGE and promoters by TAFII250 may be part of a process acting
Coomassie blue staining. The N-terminal fragment (aa 1–450) mi- to enhance the exposure of promoter elements for bind-
grates with an apparent molecular weight larger than expected,
ing by TFIID. Acetylation could positively regulate pro-owing to physical properties of its amino acid sequence. The arrow-
moter binding by TFIID directly by alleviating maskinghead indicates the position of the mutant protein (M).
of binding sites by histone amino-terminal tails or indi-
rectly by increasing promoter exposure through acetyl-
1996) and yGCN5 (J. B. and C. D. A., unpublished data), ation-induced changes in nucleosome conformation
acetylates nucleosomal histones weakly in vitro. This is (Norton et al., 1990; Bauer et al., 1994) or effects on
in contrast to the ability of P/CAF to acetylate H3 in core higher-order chromatin structure (Garcia-Ramirez et al.,
particles (Yang et al., 1996). 1992; 1995). This proposed role is not necessarily limited
Acetylation-site utilization determined by assays to promoters containing TATA elements, since TFIID
with synthetic histone amino-terminal peptides revealed plays a role in the recognition of other initiation elements
overall similarity in site utilization by hGCN5 and (e.g., the initiator) in TATA-less promoters (reviewed by
dTAFII230. Significantly, the experiments with H3 pep- Orphanides et al., 1996; Roeder, 1996; Verrijzer and
tides containing e-N-acetyllysine at distinct positions Tjian, 1996). The possible existence of histone octamer-
revealed that Lys-14 but not Lys-9 of H3 is a preferred like TAFII complexes in TFIID (Hoffmann et al., 1996; Xie
site of acetylation by both hGCN5 (Kuo et al, 1996) and et al., 1996) suggests the possibility that acetylation
dTAFII230 (Figure 5). In lower eukaryotes, acetylation at of nucleosomes by TAFII250 may facilitate nucleosome
Lys-9 is associated with deposition of newly synthesized displacement by TAFII complexes or facilitate exchange
H3 in vivo (Sobel et al., 1995), whereas Lys-14 of H3 is of histone and TAFII proteins.
preferentially acetylated by yGCN5 in vitro (Kuo et al., It seems likely that knowledge of any enzymatic activi-
1996). Thus, preferential modification of Lys-14 by ties associated with TAFIIs, such as the kinase activity
dTAFII230 is consistent with a role in transcription-asso- (Dikstein et al., 1996) or the HAT activity we describe
ciated acetylation, as suggested previously for yGCN5 here for TAFII250, will factor significantly into under-
(Brownell et al., 1996). standing TAFII function in the native context. Our finding
The basis for the observed site and substrate specific- that HAT activity is associated with a component of the
ity of dTAFII230 (or any other known HAT) with free his- preinitiation complex suggests that chromatin-modi-
fying activities associated with other components of thetones is not understood. Recently, it has been proposed
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at 48C. The supernatant constituted whole-cell extract. HeLa-celltranscriptional apparatus are likely to have important
nuclear extracts were prepared according to Dignam et al., 1983.roles in transcriptional activation from chromatin tem-
Antibodies were added to 1 ml of whole-cell extract or 100 ml ofplates.
nuclear extract and incubated at 48C for 2 hr. A 50:50 mix of Protein
A–Sepharose/Protein G–Sepharose (15 ml each) was added, and the
Experimental Procedures mixture rotated slowly overnight at 48C. Immune complexes were
pelleted by gentle centrifugation and washed three times with 1 ml
Preparation of Recombinant Proteins Lysis Buffer IPH. After the final wash, the buffer was aspirated down
Drosophila TAFII230 (Kokubo et al., 1993) and TAFII62 (Kokubo et to 30 ml. 1.25 ml of 20 mg/ml histones and 1 ml of 3H-acetyl-CoA
al., 1994a) were expressed as FLAG-tagged proteins in Sf9 cells via were added, and a HAT assay was performed at 308C. Histone
baculovirus FLAG fusions. FLAG fusions were affinity purified with acetylation was measured using the P-81 filter assay described
M2-agarose (Kodak-IBI) according to the protocols of the manufac- above.
turers. Buffer B (20 mM Tris-HCl [pH 8.0], 0.5 mM MgCl2, 10% glyc- Antibodies against CBP (PharMingen), hTAFII250, and E1A (Santa
erol, and 0.1% NP-40) supplemented with 10 mg/ml aprotinin, 10 Cruz Biotechnology) are commercially available. Antisera to TBP
mg/ml leupeptin, 1 mg/ml pepstatin A, 1 mM DTT, and 0.5 M KCl have been described previously (Pruzan et al., 1992). Other antisera
(or, in some cases, 0.15 M KCl) was used for extraction and column tested were directed against Sp1 (S. Jackson), MDM2 (A. Levine),
binding and washing. Fusion proteins were eluted with buffer B, myc (J. Pines), DNA-PK catalytic subunit (S. Jackson), hBRM (C.
supplemented as above and containing 0.1 mg/ml FLAG peptide. Muchardt), and E7 (Santa Cruz).
For yTAFII130 expression, cDNAs corresponding to the yTAFII130
portions shown in Figure 7A were amplified by PCR and subcloned Other Procedures
into E. coli expression plasmid pET28a or 6His-pET5a. Recombinant Concentrations of wild-type and mutant TAFs employed in assays
proteins were affinity purified with Ni21-NTA-agarose (Qiagen) ac- were normalized according to Coomassie blue staining of 8% SDS–
cording to the protocol of the manufacturer, except that Buffer PAGE minigels. FLAG epitope–tagged proteins were also character-
B/0.5M KCl/6M guanidine was used for chromatography. ized by immunoblotting with M2 monoclonal antisera to the FLAG
hGCN5 was expressed in E. coli strain JM109 as the 6 3 His tag (Kodak). Western blots were visualized using goat anti-mouse
fusion of the 59-BglII-39–EcoRI fragment from the original phage secondary antibodies conjugated to alkaline phosphatase following
clone (Candau et al., 1996) inserted into the pRSET vector (In- reaction with NBT and BCIP.
vitrogen) at BamHI–EcoRI sites. Crude hGCN5 was prepared by
sonicating IPTG-induced bacterial pellets in 20% sucrose, 50 mM Acknowledgments
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